Breakthrough for Narcolepsy, But What's Next?
The FDA approval of Orzeyful, a new medication targeting the orexin pathway in narcolepsy type 1 patients, marks a significant milestone in treating this debilitating condition.
The excitement surrounding this breakthrough should be tempered by consideration of its implications for those living with narcolepsy and broader sleep medicine.